Correlative Effect between in vivo Hollow Fiber Assay and Xenografts Assay in Drug Screening
Keyong Ho Lee, Ki Hyeong Rhee
Cancer Res Treat. 2005;37(3):196-200.   Published online 2005 Jun 30     DOI: https://doi.org/10.4143/crt.2005.37.3.196
Citations to this article as recorded by Crossref logo
Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux
Clarissa Willers, Hanna Svitina, Michael J. Rossouw, Roan A. Swanepoel, Josias H. Hamman, Chrisna Gouws
Journal of Cancer Research and Clinical Oncology.2019; 145(8): 1949.     CrossRef
Characterization of drug responses of mini patient‐derived xenografts in mice for predicting cancer patient clinical therapeutic response
Feifei Zhang, Wenjie Wang, Yuan Long, Hui Liu, Jijun Cheng, Lin Guo, Rongyu Li, Chao Meng, Shan Yu, Qingchuan Zhao, Shun Lu, Lili Wang, Haitao Wang, Danyi Wen
Cancer Communications.2018; 38(1): 1.     CrossRef
Anti-tumor Activity of Saussurea laniceps against Pancreas Adenocarcinoma
Keyong Ho Lee, Byeong-Soo Kim, Ki-Hyeong Rhee
Natural Product Sciences.2017; 23(4): 281.     CrossRef
Preclinical Efficacy Testing for Stomach and Liver Cancers
Jun Won Park, Nam Suk Baek, Seok Cheol Lee, Su Jin Oh, Seok Hoon Jang, In Hoo Kim, Dae Yong Kim, Hark Kyun Kim
Cancer Research and Treatment.2014; 46(2): 186.     CrossRef
Novel approaches to glioma drug design and drug screening
Shivaputra A Patil, Amira Hosni-Ahmed, Terreia S Jones, Renukadevi Patil, Lawrence M Pfeffer, Duane D Miller
Expert Opinion on Drug Discovery.2013; 8(9): 1135.     CrossRef